Li Shuang, Xu Yanwen, Wu Yuhang, Huang Heyu, Sun Chen, Xu Shanshan, Li Huajun, Zhang Xi, Zhao Shiyong, Huang Lisu
Department of Infectious Diseases, The Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, Zhejiang, People's Republic of China.
Department of Infectious Diseases, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
J Inflamm Res. 2023 Jan 26;16:321-331. doi: 10.2147/JIR.S393600. eCollection 2023.
Heparin-binding protein (HBP) is a novel biomarker for inflammatory diseases. This study aimed to investigate the role of serum HBP in community-acquired pneumonia (CAP) in children and the association of HBP with the severity and prognosis.
A total of 125 children with CAP admitted to the hospital were enrolled in this retrospective study. We analyzed the differences in clinical characteristics and examination findings between patients with different levels of HBP. The severe or complicated CAP was defined as having severe radiographic findings and/or systemic manifestations. Receiver operator characteristic (ROC) curves detected the performance of biomarkers in identifying patients with severe or complicated pneumonia. The multivariate logistic regression models assessed the association between HBP levels and the severity and prognosis. Finally, we constructed a predictive model based on HBP.
The rate of severe or complicated CAP for patients with upper-quartile HBP concentration (≥60 ng/mL) was 54.8%, significantly higher than that of patients with lower HBP concentration (26.6%). The level of HBP is substantially correlated with neutrophil counts, C-reactive protein, erythrocyte sedimentation rate, and serum amyloid A protein (r = 0.31, 0.26, 0.36, and 0.26, respectively). HBP achieved the highest level of discrimination for severe or complicated CAP among the biomarkers. Higher HBP concentration (≥60 ng/mL) was associated with a three-fold higher risk of severe or complicated CAP (adjusted odds ratio = 3.11, p < 0.05). A predictive model including four characteristics (HBP, lactate dehydrogenase, age and non-viral infection) for predicting severe or complicated CAP (with area under the ROC curve = 0.75) was built to create a nomogram.
Substantially elevated serum HBP is significantly associated with severe or complicated CAP and poor prognosis in children. This finding warrants further investigation of the function of HBP in the pathogenesis of CAP.
肝素结合蛋白(HBP)是一种用于炎症性疾病的新型生物标志物。本研究旨在探讨血清HBP在儿童社区获得性肺炎(CAP)中的作用以及HBP与病情严重程度和预后的关系。
本回顾性研究纳入了125例因CAP入院的儿童。我们分析了不同HBP水平患者的临床特征和检查结果差异。严重或复杂CAP定义为具有严重影像学表现和/或全身表现。受试者工作特征(ROC)曲线检测生物标志物在识别严重或复杂肺炎患者中的性能。多变量逻辑回归模型评估HBP水平与病情严重程度和预后的关系。最后,我们构建了基于HBP的预测模型。
HBP浓度处于上四分位数(≥60 ng/mL)的患者中严重或复杂CAP的发生率为54.8%,显著高于HBP浓度较低的患者(26.6%)。HBP水平与中性粒细胞计数、C反应蛋白、红细胞沉降率和血清淀粉样蛋白A显著相关(r分别为0.31、0.26、0.36和0.26)。在生物标志物中,HBP对严重或复杂CAP的鉴别能力最强。较高的HBP浓度(≥60 ng/mL)与严重或复杂CAP风险高三倍相关(调整优势比 = 3.11,p < 0.05)。构建了一个包含四个特征(HBP、乳酸脱氢酶、年龄和非病毒感染)的预测严重或复杂CAP的模型(ROC曲线下面积 = 0.75)以创建列线图。
血清HBP显著升高与儿童严重或复杂CAP及不良预后显著相关。这一发现值得进一步研究HBP在CAP发病机制中的作用。